The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O ‐, S,O ‐, and N , N‐ Chelate Effects-Reference-Cited by-同舟云学术

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O ‐, S,O ‐, and N , N‐ Chelate Effects

Published:2019-11-19 Issue:10 Volume:26 Page:2211-2221
ISSN:0947-6539
Container-title:Chemistry – A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Berasaluce Iker¹,Cseh Klaudia¹,Roller Alexander¹,Hejl Michaela¹,Heffeter Petra²³^ORCID,Berger Walter²³^ORCID,Jakupec Michael A.¹²^ORCID,Kandioller Wolfgang¹²^ORCID,Malarek Michael S.¹^ORCID,Keppler Bernhard K.¹²^ORCID

Affiliation:

1. Institute of Inorganic ChemistryFaculty of ChemistryUniversity of Vienna Waehringer Straße 42 1090 Vienna Austria

2. Research Cluster ‘Translational Cancer Therapy Research“University of Vienna Waehringer Straße 42 1090 Vienna Austria

3. Institute of Cancer Research and Comprehensive Cancer CenterMedical University of Vienna Borschkegasse 8a 1090 Vienna Austria

Funder

Universität Wien

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/chem.201903605

Reference59 articles.

1. MOLYBDENUM-COFACTOR–CONTAINING ENZYMES: Structure and Mechanism

2. The active sites of molybdenum- and tungsten-containing enzymes

3. The Mononuclear Molybdenum Enzymes

4. The structure and mode of action of the cofactor of the oxomolybdoenzymes

5. The Mononuclear Molybdenum Enzymes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, characterization, crystal structures and biological activity of molybdenum complexes derived from bis(acetylacetonato)dioxomolybdenum(VI) and Schiff bases;Inorganica Chimica Acta;2023-09

2. Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models;Pharmaceutics;2023-07-03

3. Metal Complexes in Cancer Treatment: Journey So Far;Chemistry & Biodiversity;2023-03-13

4. A hydrolytically stable oxo-rhenium(v) antitumor agent for synergistic combination therapy with cisplatin: from synthesis and mechanistic studies to toxicity assessment in zebrafish;Inorganic Chemistry Frontiers;2023

5. Potential scorpionate ligand derived from heterocyclic 2,4(1H,3H)-pyrimidinedithione: Synthesis, spectroscopic characterization and DFT studies;Polyhedron;2022-05